{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:06:59Z","timestamp":1781266019562,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":1587,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1111\/jth.14148","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T13:24:29Z","timestamp":1526304269000},"page":"1369-1382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Abrogating fibrinolysis does not improve bleeding or rFVIIa\/rFVIII treatment in a non\u2010mucosal venous injury model in haemophilic rodents"],"prefix":"10.1016","volume":"16","author":[{"given":"R.","family":"Stagaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Flick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bojko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Gory\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.Z.","family":"Gory\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.H.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14148_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.ATV.0000193624.28251.83","article-title":"What does it take to make the perfect clot?","volume":"26","author":"Monroe","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14148_bb0015","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1538-7836.2009.03306.x","article-title":"Discordant fibrin formation in hemophilia","volume":"7","author":"Brummel\u2010Ziedins","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0025","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood.V88.10.3815.bloodjournal88103815","article-title":"Coagulation\u2010dependent inhibition of fibrinolysis: role of carboxypeptidase\u2010U and the premature lysis of clots from hemophilic plasma","volume":"88","author":"Broze","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.14148_bb0030","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/bmj.2.5809.311","article-title":"Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease","volume":"2","author":"Forbes","year":"1972","journal-title":"Br Med J"},{"key":"10.1111\/jth.14148_bb0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2141.1971.tb07061.x","article-title":"Epsilon\u2010aminocaproic acid therapy for dental extractions in haemophilia and christmas disease: a double blind controlled trial","volume":"20","author":"Walsh","year":"1971","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14148_bb0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2516.2007.01479.x","article-title":"The use of topical crushed tranexamic acid tablets to control bleeding after dental surgery and from skin ulcers in haemophilia","volume":"13","author":"Coetzee","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0050","first-page":"272","article-title":"Tranexamic acid in the control of spontaneous bleeding in severe haemophilia","volume":"30","author":"Rainsford","year":"1973","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1111\/jth.14148_bb0055","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1136\/bmj.1.5451.1632","article-title":"Clinical trial of epsilon\u2010aminocaproic acid in severe haemophilia","volume":"1","author":"Gordon","year":"1965","journal-title":"Br Med J"},{"key":"10.1111\/jth.14148_bb0060","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00277-013-1921-z","article-title":"An in\u2010vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A","volume":"93","author":"Rea","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1111\/jth.14148_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/hae.12318","article-title":"Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors","volume":"20","author":"Tran","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0070","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/j.1538-7836.2007.02755.x","article-title":"Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A","volume":"5","author":"Hvas","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1111\/jth.14148_bb0080","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/jth.12635","article-title":"A novel F8\u2013\/\u2013 rat as a translational model of human hemophilia A","volume":"12","author":"Nielsen","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/368419a0","article-title":"Physiological consequences of loss of plasminogen activator gene function in mice","volume":"368","author":"Carmeliet","year":"1994","journal-title":"Nature"},{"key":"10.1111\/jth.14148_bb0090","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1101\/gad.9.7.794","article-title":"Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction","volume":"9","author":"Bugge","year":"1995","journal-title":"Genes Dev"},{"key":"10.1111\/jth.14148_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/hae.12907","article-title":"Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice \u2013 characterization of two novel FVIII molecules","volume":"22","author":"Johansen","year":"2016","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0100","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.STR.0000177517.01203.eb","article-title":"Tissue plasminogen activator promotes matrix metalloproteinase\u20109 upregulation after focal cerebral ischemia","volume":"36","author":"Tsuji","year":"2005","journal-title":"Stroke"},{"key":"10.1111\/jth.14148_bb0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/STROKEAHA.110.593541","article-title":"Comparative effectiveness of hemostatic therapy in experimental warfarin\u2010associated intracerebral hemorrhage","volume":"42","author":"Illanes","year":"2011","journal-title":"Stroke"},{"key":"10.1111\/jth.14148_bb0110","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1538-7836.2007.02717.x","article-title":"Evaluation of aprotinin and tranexamic acid in different in\u00a0vitro and in\u00a0vivo models of fibrinolysis, coagulation and thrombus formation","volume":"5","author":"Sperzel","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00000542-200208000-00016","article-title":"Pharmacokinetics of tranexamic acid during cardiopulmonary bypass","volume":"97","author":"Dowd","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1111\/jth.14148_bb0120","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/bja\/aet255","article-title":"Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass","volume":"111","author":"Grassin\u2010Delyle","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1111\/jth.14148_bb0125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1749-6632.1968.tb20322.x","article-title":"Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA","volume":"146","author":"Andersson","year":"1968","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/jth.14148_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2516.2011.02608.x","article-title":"Pharmacokinetics and pharmacodynamics of a new recombinant FVIII (N8) in haemophilia A mice","volume":"18","author":"Elm","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.14148_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpba.2014.01.026","article-title":"Development of SPME method for concomitant sample preparation of rocuronium bromide and tranexamic acid in plasma","volume":"92","author":"Gorynski","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"10.1111\/jth.14148_bb0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2009.03.006","article-title":"Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor","volume":"125","author":"White","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14148_bb0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.thromres.2008.11.001","article-title":"Comparative hemostatic parameters in BALB\/c, C57BL\/6 and C3H\/He mice","volume":"124","author":"Barrios","year":"2009","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14148_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2326-6-6","article-title":"Genetic background determines response to hemostasis and thrombosis","volume":"6.1","author":"Hoover\u2010Plow","year":"2006","journal-title":"BMC Hematology"},{"key":"10.1111\/jth.14148_bb0160","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1161\/01.CIR.92.9.2585","article-title":"Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice","volume":"92","author":"Ploplis","year":"1995","journal-title":"Circulation"},{"key":"10.1111\/jth.14148_bb0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/hae.13126","article-title":"F376A\/M388A\u2010solulin, a new promising antifibrinolytic for severe haemophilia A","volume":"23","author":"Parcq","year":"2017","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0170","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1182\/blood-2011-11-392308","article-title":"Solulin increases clot stability in whole blood from humans and dogs with hemophilia","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.14148_bb0175","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2141.2008.07063.x","article-title":"Thromboelastography in children with coagulation factor deficiencies","volume":"142","author":"Chitlur","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14148_bb0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2516.2003.00767.x","article-title":"Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia","volume":"9","author":"Ingerslev","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0185","first-page":"126","article-title":"Guideline for the treatment of haemophilia in South Africa","volume":"98","author":"Mahlangu","year":"2008","journal-title":"S Afr Med J"},{"key":"10.1111\/jth.14148_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1834-7819.2001.tb00272.x","article-title":"A protocol for the dental management of von Willebrand's disease, haemophilia A and haemophilia B","volume":"46","author":"Stubbs","year":"2001","journal-title":"Aust Dent J"},{"key":"10.1111\/jth.14148_bb0195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2257.2004.00590.x","article-title":"Management of haemophilia and its complications in developing countries","volume":"26","author":"Ghosh","year":"2004","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.14148_bb0200","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2516.2003.00765.x","article-title":"Continuous infusion","volume":"9","author":"Schulman","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0205","first-page":"S97","article-title":"Experiences with continuous infusion of recombinant activated factor VII","volume":"9","author":"Schulman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14148_bb0210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1351-8216.2003.00839.x","article-title":"Role of epsilon amino caproic acid in the management of haemophilic patients with inhibitors","volume":"10","author":"Ghosh","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0215","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1111\/hae.12942","article-title":"Multimodal blood loss prevention approach including intra\u2010articular tranexamic acid in primary total knee arthroplasty for patients with severe haemophilia A","volume":"22","author":"Rodriguez\u2010Merchan","year":"2016","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14148_bb0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0140-6736(62)90265-9","article-title":"Effect of \u03a3\u2010aminocaproic acid in haemophilia","volume":"280","author":"Abe","year":"1962","journal-title":"Lancet"},{"key":"10.1111\/jth.14148_bb0225","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-2141.1965.tb00117.x","article-title":"Fibrinolysis in haemophilia: the effect of \u03b5\u2010amino\u2010caproic acid","volume":"11","author":"Mainwaring","year":"1965","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14148_bb0230","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00000441-196505000-00005","article-title":"The role of fibrinolysin and profibrinolysin activator in hemophilia","volume":"249","author":"Reid","year":"1965","journal-title":"Am J Med Sci"},{"key":"10.1111\/jth.14148_bb0235","first-page":"772","article-title":"Dose\u2010response and duration of effect of a half\u2010life extended recombinant factor VIIa in the tail vein transection bleeding model in haemophilia rats","volume":"1","author":"Elm","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0240","first-page":"315","article-title":"In vivo effect of recombinant FVIIa (NovoSeven\u00ae) and rFIX in a refined tail vein transection bleeding model in anesthetized mice with hemophilia A or B","volume":"13","author":"Johansen","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0245","doi-asserted-by":"crossref","first-page":"e0122196","DOI":"10.1371\/journal.pone.0122196","article-title":"Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site\u2010dependent plasminogen accumulation in microthrombi","volume":"10","author":"Brzoska","year":"2015","journal-title":"PLoS One"},{"key":"10.1111\/jth.14148_bb0250","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0037-1615666","article-title":"A tail vein bleeding time model and delayed bleeding in hemophiliac mice","volume":"85","author":"Broze","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V99.1.175","article-title":"Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A","volume":"99","author":"Lisman","year":"2002","journal-title":"Blood"},{"key":"10.1111\/jth.14148_bb0260","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1055\/s-0037-1616530","article-title":"The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration","volume":"86","author":"Mosnier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0265","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1182\/blood-2010-08-303677","article-title":"Evaluation of the profibrinolytic properties of an anti\u2010TAFI monoclonal antibody in a mouse thromboembolism model","volume":"117","author":"Vercauteren","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.14148_bb0270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/jth.12062","article-title":"Plasmin and the thrombin\u2013thrombomodulin complex both contribute to thrombin\u2010activatable fibrinolysis inhibitor activation in whole blood model thrombi","volume":"11","author":"Vercauteren","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0275","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI0212119","article-title":"Thrombin\u2010activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life","volume":"109","author":"Nagashima","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.14148_bb0280","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1160\/TH06-09-0552","article-title":"A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) \u2013 part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis","volume":"97","author":"Wang","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14148_bb0285","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1111\/j.1365-2516.2011.02648.x","article-title":"Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A","volume":"18","author":"Foley","year":"2012","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14148","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622023352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622023352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.14148\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:21:02Z","timestamp":1761535262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622023352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1538783622023352"],"URL":"https:\/\/doi.org\/10.1111\/jth.14148","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abrogating fibrinolysis does not improve bleeding or rFVIIa\/rFVIII treatment in a non\u2010mucosal venous injury model in haemophilic rodents","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Novo Nordisk A\/S, Journal of Thrombosis and Haemostasis. International Society on Thrombosis","name":"copyright","label":"Copyright"}]}}